Spherics Inc.
This article was originally published in Start Up
Executive Summary
Spherics' intellectual property, which emanates from Brown University, centers on two separate drug delivery platforms. A bioadhesive platform allows drugs to adhere to mucosal surfaces, to increase residence time and consequent drug absorption. A second technology permits the nano-encapsulation of drugs in microspheres in a wide range of sizes, under gentle process conditions that don't harm biomolecules.